by CN Bio | Nov 11, 2019 | Press releases
Leading bioengineering company CN Bio has launched a fee for service program providing Human Organ-on-Chip data to scientists studying non-alcoholic steatohepatitis (NASH) therapeutics. CN Bio launched the program at the American Association for the Study of Liver...
by CN Bio | May 1, 2019 | Press releases
Organ-on-Chip specialist CN Bio has signed a distribution agreement with Sydney-based AXT Pty. Ltd., Australia’s leading supplier of high technology scientific equipment. The agreement will see AXT distribute CN Bio’s innovative bioengineering products to medical...
by CN Bio | Feb 28, 2019 | Press releases
London Organ-on-Chip specialist CN Bio today announced it has secured an exclusive license to technology from the Massachusetts Institute of Technology for Organ-on-Chip systems which connect human tissues from up to 10 organs. CN Bio participated with MIT on a...
by CN Bio | Nov 22, 2018 | Press releases
The PhysioMimix™ benchtop 3D cell culture system from CN Bio has won the Innovation Award at the UK’s largest laboratory event, held at the NEC Birmingham in November. PhysioMimix™ allows researchers to set up assays and generate results quickly. Scientists and...
by CN Bio | Jul 19, 2018 | Press releases
London, UK, 19 July 2018: CN Bio Innovations Limited today announced that its Board of Directors has accepted the resignation of Dr Emma Sceats as CEO and Director of CN Bio and appointed Dr David Hughes as Chief Executive Officer effective immediately. Dr Hughes has...
by CN Bio | May 23, 2018 | Press releases
London, UK, 23 May 2018: CN Bio Innovations Limited today launched PhysioMimix, a printer-sized device which allows scientist to conduct organ-on-chip studies in their own labs, testing new drugs and chemicals on living human organ models. Dr Emma Sceats, CEO of CN...
